Literature DB >> 1563323

Effect of somatostatin analog octreotide on human sphincter of Oddi.

K F Binmoeller1, R Dumas, A G Harris, J P Delmont.   

Abstract

The effect of the long-acting somatostatin analog octreotide on the sphincter of Oddi was investigated in seven subjects referred for endoscopic sphincter of Oddi manometry. Six patients had unexplained right upper quadrant pain and one had bile duct dilatation without evidence of fixed obstruction on endoscopic retrograde cholangiopancreatography. A triple-lumen low-compliance system was used to record the sphincter of Oddi basal pressure, phasic contraction frequency, amplitude, duration, and direction of wave propagation before and after intravenous administration of octreotide in a dose of 50 micrograms. After a mean latency period of 1 min, significant changes included increased basal pressure in all seven patients, increased frequency of wave contractions in six patients, and decreased wave amplitude in six patients. The median duration of wave contraction and wave propagation sequence were not significantly influenced. Thus, octreotide has a significant stimulatory affect on the sphincter of Oddi activity, which may impair biliary and pancreatic flow.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1563323     DOI: 10.1007/bf01296438

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  19 in total

1.  Manometric evaluation of the papillar of Vater.

Authors:  O T Nebel
Journal:  Gastrointest Endosc       Date:  1975-02       Impact factor: 9.427

2.  Severe acute pancreatitis complicating sphincter of Oddi manometry.

Authors:  M B Albert; W M Steinberg; S K Irani
Journal:  Gastrointest Endosc       Date:  1988 Jul-Aug       Impact factor: 9.427

3.  Pharmacologic effect of somatostatin on bile formation in the dog. Enhanced ductular reabsorption as the major mechanism of anticholeresis.

Authors:  E René; R G Danzinger; A F Hofmann; M Nakagaki
Journal:  Gastroenterology       Date:  1983-01       Impact factor: 22.682

4.  Effect of somatostatin on determinants of bile flow in unanesthetized dogs.

Authors:  M H Lewis; A L Baker; E Ipp; A R Moossa
Journal:  Ann Surg       Date:  1982-01       Impact factor: 12.969

Review 5.  Sphincter of Oddi motility.

Authors:  J Toouli
Journal:  Br J Surg       Date:  1984-04       Impact factor: 6.939

6.  Action of cholecystokinin and caerulein on the rabbit sphincter of Oddi.

Authors:  J C Sarles; J M Bidart; M A Devaux; C Echinard; A Castagnini
Journal:  Digestion       Date:  1976       Impact factor: 3.216

7.  Influence of motilin and cholecystokinin on sphincter of Oddi and duodenal mobility.

Authors:  E L Muller; P A Grace; R L Conter; J J Roslyn; H A Pitt
Journal:  Am J Physiol       Date:  1987-11

8.  Intraluminal pressure recording from the human sphincter of Oddi.

Authors:  J E Geenen; W J Hogan; W J Dodds; E T Stewart; R C Arndorfer
Journal:  Gastroenterology       Date:  1980-02       Impact factor: 22.682

9.  Why does somatostatin cause gallstones?

Authors:  S A Ahrendt; G E McGuire; H A Pitt; K D Lillemoe
Journal:  Am J Surg       Date:  1991-01       Impact factor: 2.565

10.  Effect of gastrointestinal hormones on the biliary sphincter of the opossum.

Authors:  J M Becker; F G Moody; A R Zinsmeister
Journal:  Gastroenterology       Date:  1982-06       Impact factor: 22.682

View more
  18 in total

1.  Intravenous bolus somatostatin after diagnostic cholangiopancreatography reduces the incidence of pancreatitis associated with therapeutic endoscopic retrograde cholangiopancreatography procedures: a randomised controlled trial.

Authors:  R T-P Poon; C Yeung; C-L Liu; C-M Lam; W-K Yuen; C-M Lo; A Tang; S-T Fan
Journal:  Gut       Date:  2003-12       Impact factor: 23.059

2.  Effect of octreotide on human sphincter of Oddi motility following liver transplantation.

Authors:  F H Weber; R J Sears; B Kendall; T L Pruett; H A Shaffer; P Yeaton
Journal:  Dig Dis Sci       Date:  1997-06       Impact factor: 3.199

3.  Effect of octreotide on sphincter of Oddi motility in patients with acute recurrent pancreatitis: a manometric study.

Authors:  V Di Francesco; G Angelini; P Bovo; M B Casarini; M Filippini; B Vaona; L Frulloni; L Rigo; M P Brunori; G Cavallini
Journal:  Dig Dis Sci       Date:  1996-12       Impact factor: 3.199

Review 4.  Predicting and preventing post-ERCP pancreatitis.

Authors:  John Baillie
Journal:  Curr Gastroenterol Rep       Date:  2002-04

5.  Comparison of post-ERCP biological pancreatitis in chronic alcoholic and control nonalcoholic group.

Authors:  P Hastier; A G Harris; F X Caroli-Bosc; R Dumas; J P Delmont
Journal:  Dig Dis Sci       Date:  1996-03       Impact factor: 3.199

Review 6.  Infected pancreatic necrosis.

Authors:  C Bassi
Journal:  Int J Pancreatol       Date:  1994-08

7.  Development of the endocrine cells in the rat pancreatic and bile duct system.

Authors:  I S Park; M Bendayan
Journal:  Histochem J       Date:  1993-11

Review 8.  Can postendoscopic retrograde cholangiopancreatography pancreatitis be prevented by a pharmacological approach?

Authors:  Young Koog Cheon
Journal:  Korean J Intern Med       Date:  2013-02-27       Impact factor: 2.884

9.  Sphincter of Oddi dysfunction in children.

Authors:  Moises Guelrud; Leonel Rodriguez
Journal:  Curr Gastroenterol Rep       Date:  2006-04

10.  Does the somatostatin analogue octreotide protect against ERCP induced pancreatitis?

Authors:  K F Binmoeller; A G Harris; R Dumas; C Grimaldi; J P Delmont
Journal:  Gut       Date:  1992-08       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.